Skandinaviska Enskilda Banken Ab (Publ) Kura Oncology, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $20.7 Billion
- Q2 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 53,738 shares of KURA stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
53,738
Previous 53,738
-0.0%
Holding current value
$1.05 Million
Previous $1.15 Million
3.49%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$138 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$136 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$113 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$106 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$88.6 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.31B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...